Literature DB >> 6402240

Hypercalcaemic sarcoidosis in hypoparathyroidism.

T H Mitchell, T C Stamp, M V Jenkins, E B Mawer, J L Berry.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6402240      PMCID: PMC1546991          DOI: 10.1136/bmj.286.6367.764

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


× No keyword cloud information.
  5 in total

1.  Hypercalcemia during long-term treatment with 1,25-dihydroxyvitamin D3 in hypoparathyroidism.

Authors:  N H Bell; S Epstein; P H Stern
Journal:  N Engl J Med       Date:  1979-11-22       Impact factor: 91.245

2.  Measurement of 1,25-dihydroxycholecalciferol in man by radioimmunoassay.

Authors:  T L Clemens; G N Hendy; S E Papapoulos; L J Fraher; A D Care; J L O'Riordan
Journal:  Clin Endocrinol (Oxf)       Date:  1979       Impact factor: 3.478

3.  Evidence that increased circulating 1 alpha, 25-dihydroxyvitamin D is the probable cause for abnormal calcium metabolism in sarcoidosis.

Authors:  N H Bell; P H Stern; E Pantzer; T K Sinha; H F DeLuca
Journal:  J Clin Invest       Date:  1979-07       Impact factor: 14.808

4.  Vitamin D metabolism in hypoparathyroidism.

Authors:  B Lund; O H Sørensen; B Lund; J E Bishop; A W Norman
Journal:  J Clin Endocrinol Metab       Date:  1980-09       Impact factor: 5.958

5.  1, 25-dihydroxycholecalciferol in the pathogenesis of the hypercalcaemia of sarcoidosis.

Authors:  S E Papapoulos; T L Clemens; L J Fraher; I G Lewin; L M Sandler; J L O'Riordan
Journal:  Lancet       Date:  1979-03-24       Impact factor: 79.321

  5 in total
  1 in total

Review 1.  Calcium and vitamin D metabolism in granulomatous diseases.

Authors:  M Fuss; T Pepersack; C Gillet; R Karmali; J Corvilain
Journal:  Clin Rheumatol       Date:  1992-03       Impact factor: 2.980

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.